India’s regulatory reforms on compensation for clinical trial injuries and deaths: urgent need for revisiting

Jerome Amir Singh

DOI: 10.20529/IJME.2013.057


Abstract

Financial compensation to participants in clinical trials for the immediate and long-term medical treatment of injuries sustained while participating in the trials, and payment to their next of kin when such injuries result in death, is a relatively neglected subject, particularly in developing countries.

Full Text

HTML PDF

Keywords

N/A

Refbacks

There are currently no refbacks.